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Abstract
Background: Epistasis, i.e., the interaction of alleles at different loci, is thought to play a central role in the formation and
progression of complex diseases. The complexity of disease expression should arise from a complex network of epistatic
interactions involving multiple genes.
Methodology: We develop a general model for testing high-order epistatic interactions for a complex disease in a case-
control study. We incorporate the quantitative genetic theory of high-order epistasis into the setting of cases and controls
sampled from a natural population. The new model allows the identification and testing of epistasis and its various genetic
components.
Conclusions: Simulation studies were used to examine the power and false positive rates of the model under different
sampling strategies. The model was used to detect epistasis in a case-control study of inflammatory bowel disease, in which
five SNPs at a candidate gene were typed, leading to the identification of a significant three-locus epistasis.
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Introduction
The complexity of biological systems arises from the highly
interactive relationships of their components [1,2]. Thus, it is likely
that the metabolic pathways for a phenotypic trait or disease
involve multiple interacting gene products and regulatory loci that
could generate a complex network of genetic actions and
interactions [3,4]. Current genome-wide linkage or association
studies have been able to detect genetic actions of individual genes
involved in the phenotypic diversity of a complex trait [5–12].
Given its ubiquitousness in controlling complex traits and diseases,
epistasis resulting from interactions between alleles at different
genes has now received increasing attention in genetic studies
[13,14]. However, many of these studies focus on the identification
of low-order pairwise epistasis, leaving epistatic interactions of
high orders, their frequency and impact on genetic variation,
unexplored.
More recently, Stich et al. [15] developed a linkage mapping
approach to uncover three-way interactions among different
quantitative trait loci (QTLs) using a mating design. Beerenwinkel
et al. [16] proposed a mathematical approach for describing multi-
way genetic interactions and employing it to study the genetic
structure of fitness landscapes for Escherichia coli. Based on the
analysis of pathway fragments, Imielinski and Belta [17] used a
genome-scale knockout design to detect high-order epistatic
relationships between components of large metabolic networks.
Hansen and Wagner [18] showed that higher-order genetic
interactions are potentially important if the total genomic
mutation rate is large and the interaction density among loci is
not too low. With the widespread availability of high-throughpout
genotyping technology, there is a pressing need to estimate higher-
order epistasis involving any number of genes and assess the role of
epistasis in the creation and maintenance of genetic variation for
complex traits.
The motivation of this study is to develop a general model for
estimating epistasis of any order with multilocus single
nucleotide polymorphism (SNP) data in case-control studies.
In particular, the model allows the estimation and testing of
high-order epistasis. Because of its easy sample collection, a
population-based case-control design has been widely used in
candidate gene or genome-wide association studies [19–21]. By
comparing genotype frequencies for a gene in unrelated
individuals with the disease and healthy controls, this design
has power to test the significance of the association between the
gene and disease. However, only a few studies used a case-
control design to characterize epistasis [19] and, also, the
epistasis they defined on the basis of logistic regression models
presents a computational complexity. The new model described
in this article has, for the first time, embedded quantitative
genetic principles into a chi-square test framework, allowing the
dissection of overall multilocus genetic effects into various
components including epistatic interactions of high orders. The
model was validated through simulation studies and a real data
analysis.
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e11384Large Quantitative Genetic Models for Epistasis
Epistasis was originally defined as the expression of an allele at
one locus masked by an allele at another locus [22]. This concept
was then explained in a statistical manner by Fisher [23] as the
deviation of genetic action from additivity in a linear model.
Fisher’s definition allows epistasis to be quantified in different
forms based on its biological meaning determined by Bateson [22].
For a two-locus epistasis, all possible forms of epistasis include the
interactions between additive effects at the two loci, additive effect
at the first locus and dominant effect at the second locus, dominant
effect at the first locus and additive effect at the second locus, and
dominant effects at the two loci. Each of these epistatic forms
contributes differently to the overall genetic value of a two-locus
genotype. We used Mather and Jinks’ formulation [24] to partition
a genotypic value into its different components including epistasis.
Two-locus Epistasis
Suppose there are two loci, A with two alleles A and a and B
with two alleles B and b, which form nine two-locus genotypes. Let
mj1j2 denote the genetic value of an arbitrary genotype j1j2
(j1~2,1,0 for genotypes AA, Aa, and aa; j2~2,1,0 for genotypes
BB, Bb, and bb, respectively). We dissect mj1j2 into different
components as table 1.
Where m is the overall mean, a1 and a2 are the additive effect at
genes A and B, d1 and d2 are the dominant effect at genes A and
B, respectively, and iaa, iad, ida, and idd are the additive |
additive, additive | dominant, dominant | additive, and
dominant | dominant epistatic interactions between the two
genes, respectively.
The dissection of genotypic values is expressed, in matrix form,
as
m00
m01
m02
m10
m11
m12
m20
m21
m22
                                           
                                           
~
1 {1 {100 1 0 00
1 {10 0 10 {10 0
1 {11 0 0 {100 0
10 {1 1 000 {10
1 0 011 0 0 01
1 0 110 0 0 10
11 {100{100 0
1 1 001 0 1 00
1 1 100 1 0 00
                                           
                                           
|
m0
a1
a2
d1
d2
iaa
iad
ida
idd
                                           
                                           
ð1Þ
The genetic effect parameters can be solved using
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Three-locus Epistasis
Adding a locus, C with two alleles C and c, to the two-gene
model generates 27 three-locus genotypes, expressed as j1j2j3
(j3~2,1,0 for genotypes CC, Cc, and cc, respectively). A three-
genotypic value (mj1j2j3) is dissected into the following components:
(1) the overall mean m;
(2) the main genetic effects including the three additive effects (a1,
a2, and a3) at genes A, B, and C, and the three dominant
effects (d1, d2, and d3) at genes A, B, and C;
(3) the two-way interaction effects including the additive |
additive (ia1a2), additive | dominant (ia1d2), dominant |
additive (id1a2), and dominant | dominant (id1d2) epistasis
between genes A and B, the additive | additive (ia1a3),
additive | dominant (ia1d3), dominant | additive (id1a3), and
dominant | dominant (id1d3) epistasis between genes A and
C, and additive | additive (ia2a3), additive | dominant (ia2d3),
dominant | additive (id2a3), and dominant | dominant (id2d3)
epistasis between genes B and C;
(4) the three-way interaction effects including the additive |
additive | additive (ia1a2a3), additive | additive | dominant
(ia1a2d3), additive | dominant | additive (ia1d2a3), dominant |
additive | additive (id1a2a3), additive | dominant | dominant
(ia1d2d3), dominant | additive | dominant (id1a2d3), domi-
nant | additive | dominant (id1a2d3), and dominant |
dominant | dominant (id1d2d3) epistasis among genes A, B,
and C.
Mather and Jinks’ theory is used to formulate the relationships
between genotypic values and genetic effects, expressed as
Table 1. The genetic effect components of two-locus genotypes.
Component
Genotype Value m a1 a2 d1 d2 iaa iad ida idd
AABB m22 +++ +
AABb m21 ++ + +
AAbb m20 ++{{
AaBB m12 ++ + +
AaBb m11 ++ + +
Aabb m10 + { + {
aaBB m02 + { + {
aaBb m01 + { + {
aabb m00 + {{ +
doi:10.1371/journal.pone.0011384.t001
ð2Þ
High-Order Epistasis
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The genetic effect parameters are then solved from the genotypic
values:
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N-locus Epistasis
We propose a general model for describing genetic components
for a genotype composed of any number of loci. Consider n loci
which form 3n genotypes. The value of a n-locus genotype is
composed of the overall mean, the additive and dominant effects
for each locus, and epistasis of different kinds and orders among
these loci. Let the space of the genetic effects at individual loci be
defined as e1 [(w,a1,d1) for gene 1, e2 [(w,a2,d2) for gene 2, …,
en [(w,an,dn) for gene n. Thus, we can define all possible genetic
effects (ee1,e2,:::,en)a s
ð3Þ
ð4Þ
High-Order Epistasis
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N If e1~a1,e2~e3~:::~en~w, then ea1,w,:::,w~a1;
N …;
N If e1~a2,e2~a2,e3~e4~:::~en~w, then ea1,a2,w,:::,w~ia1a2;
N …;
N If e1~a1, e2~a2,… , en~an, then ea1,a2,:::,an~ia1a2:::an.
N …;
N If e1~d1, e2~d2,… , en~dn, then ed1,d2,:::,dn~id1d2:::dn.
By letting wl~0, al~1 and dl~2 (l~1,:::,n), we express the
value of a general multi-locus genotype as
mj1j2:::jn~
X 2
en~0
   
X 2
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L is a logical judgment function that can return 1 if the condition is
true otherwise return 0.
The genetic effect parameters can be estimated by solving the
linear equations using
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Equation (8) gives a general form for main and interaction
genetic effects among an arbitrary number of loci. Mathematical
algorithms for solving epistatic equations are given in Text S1.
Testing Epistasis
Based on the definitions, we now provide a procedure for testing
epistasis of different kinds and orders with multilocus genetic data.
Consider a case-control study in which m cases (there is a disease)
and n controls (there is no disease) are selected randomly from a
natural population. Case and control groups are matched for
demographical factors such as age, race, gender, life style, and
body mass. All subjects from the case and control groups are
genotyped genome-wide or for particular chromosomal regions of
interest, depending on the purpose of the study. Let m
(1)
j1j2j3 and
m
(2)
j1j2j3 denote the observations of a general genotype j1j2j2
(j1,j2,j3~2,1,0) derived from three markers A, B, and C. Based
on Mather and Jinks’ partition of genotypic values [24], we
calculate genetic effect parameters from genotypic values using
equation (4). For both cases and controls, the genotypic values
used to calculate each effect parameter are dissolved into two
groups, plus and minus, which forms a 2 (cases and control)|2
(plus and minus) contingency table. For example, the contingency
table for testing the additive|additive|additive epistatic effect is
expressed as table 2.
From the table, the x2 test statistic is calculated and compared
with the critical threshold with one degree of freedom. We proved
that the test statistics under the null hypothesis calculated from the
above contingency table follows a x2 distribution with less than
one degree of freedom [25].
The contingency tables for testing the other parameters can be
made similarly. For a particular group k (k=1 for cases, 2 for
controls), the genotypic values used to calculate the three-way
epistatic effect parameters are tabulated as table 3.
The thresholds for testing each of these three-locus epistases are
derived, which are x2
0:05 =3.84, 3.20, 3.20, 3.20, 2.60, 2.60, 2.60,
and 2.14, respectively. The genotypic values used to calculate the
two-way epistatic effect parameters are tabulated as table 4.
The thresholds for testing each of these two-locus epistases are
derived, which are x2
0:05 =3.84, 3.84, 3.84, 2.50, 2.50, 2.50, 3.20,
3.20, 3.20, 3.20, 3.20 and 3.20, respectively. The genotypic values
used to calculate the main genetic effect parameters are tabulated
as table 5.
The thresholds for testing each of these two-locus epistases are
derived, which are x2
0:05 =3.84, 3.84, 3.84, 2.60, 2.60 and 2.60,
respectively. For an arbitrary number of markers, the genotypic
values used to calculate the main and epistatic (of different orders)
genetic effect parameters can be similarly divided into plus and
minus groups, from which the x2 test statistics are calculated.
Results
The model was used to analyze a case-control study aimed to
detect genetic variants for inflammatory bowel disease (IBD) with
candidate gene approaches [26]. As a member of the membrane
associated guanylate kinase family, TDiscs large homolog (DLG5)
plays a central role in maintaining cell junctions and cell shape and
in clustering channel proteins at the cell surface [27]. Five single
nucleotide polymorphisms (SNPs), Arg30Gln, Glu514Gln,
Pro979Leu, Gly1066Gly, and Pro1371Gln, genotyped at DLG5
for both cases and controls are hoped to be associated with IBD.
The cases include 115 sporadic IBD patients, aged from 22 to 66
years old, from the Milton S Hershey Medical Center, whereas the
controls are 172 unrelated healthy individuals, aged from 15 to 81
Table 2. The x2 test statistics for the
additive|additive|additive epistatic effect.
Plus Minus
Cases m
(1)
222zm
(1)
200zm
(1)
020zm
(1)
002 m
(1)
220zm
(1)
202zm
(1)
022zm
(1)
000
Controls m
(2)
222zm
(2)
200zm
(2)
020zm
(2)
002 m
(2)
220zm
(2)
202zm
(2)
022zm
(2)
000
doi:10.1371/journal.pone.0011384.t002
ð5Þ
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Philadelphia gift of Life Donor Program. All the human tissues
used for pathological studies and genetic analysis were approved
by the Human Subjects Protection Offices of The Pennsylvania
State University College of Medicine, and were undertaken with
the understanding and written consent of each subject.
Because of a modest sample size used, our analysis will focus on
a three-SNP analysis, although the model can deal with any
number of SNPs. None of the five SNPs displays an additive
genetic effect, but Arg30Gln, Pro979Leu, and Gly1066Gly were
each found to trigger a significant dominant effect on the disease
(p~0:04{0:0002) (table 6). There are 10 possible pairs for the five
SNPs, with each pair subject to a two-locus epistatic analysis. The
number and distribution of two-locus epistasis are given in table 7.
It is interesting to see that significant two-locus epistasis was
observed only between Arg30Gln and other SNPs including
Pro979Leu with a significant main dominant effect and two non-
significant SNPs (Glu514Gln and Pro1371Gln). The form of
significant epistasis is limited to the interactions between the
dominant effect at Arg30Gln and the additive/dominant effects at
the other SNPs.
The five SNPs produce 10 three-locus combinations which were
analyzed by a three-locus epistasis model. Each combination has
eight forms of three-SNP epistasis. Table 8 lists the test statistics for
all possible combinations and forms of epistasis, with significant
epistasis highlighted in boldface. The interactions among the
additive effects at any three of the five SNPs were not significant;
the same was also observed for the three-way dominant
interactions. The significant three-locus epistasis must include
both the additive and dominant effect at three SNPs. In general,
Arg30Gln have more significant three-locus interactions and
Table 3. The x2 test statistics for the three-way epistatic effect parameters.
Parameter Plus Minus
ia1a2a3 m
(k)
222zm
(k)
200zm
(k)
020zm
(k)
002 m
(k)
220zm
(k)
202zm
(k)
022zm
(k)
000
ia1a2d3 2m
(k)
221zm
(k)
202zm
(k)
200zm
(k)
022zm
(k)
020z2m
(k)
001 m
(k)
222zm
(k)
220z2m
(k)
201z2m
(k)
021zm
(k)
002zm
(k)
000
ia1d2a3 m
(k)
220z2m
(k)
212zm
(k)
200zm
(k)
022z2m
(k)
010zm
(k)
002 m
(k)
222z2m
(k)
210zm
(k)
202zm
(k)
020z2m
(k)
012zm
(k)
000
ia1d2d3 m
(k)
222zm
(k)
220z4m
(k)
211zm
(k)
202zm
(k)
200z2m
(k)
201z2m
(k)
012z2m
(k)
010z2m
(k)
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221z2m
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(k)
210z2m
(k)
201zm
(k)
022zm
(k)
020z4m
(k)
011zm
(k)
002zm
(k)
000
id1a2a3 m
(k)
220zm
(k)
202z2m
(k)
122z2m
(k)
100zm
(k)
020zm
(k)
002 m
(k)
222zm
(k)
200z2m
(k)
120z2m
(k)
102zm
(k)
022zm
(k)
000
id1a2d3 m
(k)
222zm
(k)
220z2m
(k)
201z4m
(k)
121z2m
(k)
102z2m
(k)
100zm
(k)
022zm
(k)
020z2m
(k)
001 2m
(k)
221zm
(k)
202zm
(k)
200z2m
(k)
122z2m
(k)
120z4m
(k)
101z2m
(k)
021zm
(k)
002zm
(k)
000
id1d2a3 m
(k)
222z2m
(k)
210zm
(k)
202z2m
(k)
120z4m
(k)
112z2m
(k)
100zm
(k)
022z2m
(k)
010zm
(k)
002 m
(k)
220z2m
(k)
212zm
(k)
200z2m
(k)
122z4m
(k)
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(k)
102zm
(k)
020z2m
(k)
012zm
(k)
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id1d2d3 2m
(k)
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(k)
212z2m
(k)
210z2m
(k)
201z2m
(k)
122z2m
(k)
120z8m
(k)
111z2m
(k)
102z
2m
(k)
100z2m
(k)
021z2m
(k)
012z2m
(k)
010z2m
(k)
001
m
(k)
222zm
(k)
220z4m
(k)
121z4m
(k)
112z4m
(k)
110z4m
(k)
101zm
(k)
022zm
(k)
020z
4m
(k)
011zm
(k)
002zm
(k)
000
doi:10.1371/journal.pone.0011384.t003
Table 4. The x2 test statistics for the two-way epistatic effect
parameters.
Parameter Plus Minus
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Table 5. The x2 test statistics for the main epistatic effect
parameters.
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Arg30Ln, Glu514Gln, and Pro979Leu produce the most numer-
ous forms of epistasis (3), followed by the combinations of
Arg30Ln, Gly1066Gly, and Pro1371Gln (2), Glu514Gln,
Gly1066Gly, and Pro1371Gln (2), Arg30Ln, Glu514, and
Pro1371Gln (1), Arg30Ln, Pro979Leu, and Pro1371Gln (1),
Pro979Leu, Gly1066Gly, and Pro1371Gln (1). The three SNPs
with significant main effects (Arg30Ln, Pro979Leu, and
Pro1371Gln) do not produce a significant three-locus epistatic
interaction. The two SNPs displaying non-significant main effects
(Glu514Gln and Pro1371Gln) could generate significant three-
locus interactions with SNPs Arg30Ln and Gly1066Gly but not
with Pro979Leu (table 8).
After significant high-order epistasis is detected, the next step is
to make a biological interpretation of such epistasis. To interpret
it, we will use the dominant (d)|additive (a)|additive (a) epistasis
among Arg30Ln, Glu514Gln, and Pro979Leu as an example.
Table 9 gives the structure of genetic effects for each three-locus
genotypic value in terms of the additive, dominant, and epistatic
effects of different orders. The d|a|a epistasis only contributes
to the genotypic value of AaBBCC, AaBBcc, AabbCC, and
Aabbcc (table 9). For each of these four genotypes, their values are
partitioned into different effect components for both cases and
controls (table 10). As can be seen, the d|a|a epistasis increases,
by 9 cases, the incidence of IBD for those with genotype AaBBCC
or Aabbcc, but decreases the IBD incidence of those carrying
genotype AaBBcc or AabbCC with the same extent.
Computer Simulation
Simulation studies were undertaken to examine the statistical
behavior of the new model. We will focus on the investigation of
the power and false positive rates (FDR) for the detection of three-
locus epistasis. Three different simulation schemes will be used
with varying numbers of cases vs. controls, 200 vs. 200, 400 vs.
400, and 1000 vs. 1000. The eight possible forms of three-locus
epistasis can be sorted into four presentative ones, (1) additive|
additive|additive (no dominant effect), (2) additive|additive|
dominant, additive|dominant|additive, and dominant|
additive|additive (no one dominant effect), (3) additive|
dominant|dominant, dominant|additive|dominant, and dom-
inant|dominant|additive (two dominant effects), and (4)
dominant|dominant|dominant (three dominant effects).
For a real data set, different SNPs may be associated or
independent of each other. We will investigate how SNP-SNP
associations affect the behavior of the new model. In one data set,
three SNPs with the same allele frequency were simulated with
pair-wise and three-locus linkage disequilibria. Among the three
SNPs, only additive|additive|additive, additive|additive|
dominant, additive|dominant|dominant, and dominant|
dominant|dominant were assumed to exist. This can be done
by simulating a contingency table with constraints x2
a1a2a3w
x2
0:05~3:84, x2
a1a2d3wx2
0:05~3:20, x2
a1d2d3wx2
0:05~3:20, x2
d1d2d3w
x2
0:05~2:14 and the test statistics for the other effects w the
corresponding thresholds. The same parameters, except that there
is no linkage disequilibrium, were used to simulate the second data
set containing three SNPs.
Table 11, table 12, and table 13 give the power and false
positive error rates (FPR) of the three-locus interaction detection
by the new epistatic models. The power to detect the three-locus
epistasis increase remarkably with sample size in a case-control
study. With sample sizes of 200 vs. 200, there is power of about
0.51–0.61, with the additive|additive|additive epistasis detected
most easily, followed by the additive|additive|dominant
epistasis, the additive|dominant|dominant epistasis, and the
dominant|dominant|dominant epistasis. When sample sizes
increase to 400 vs. 400, the power for the three-locus epistasis
detection will surpass three quarters. If sample sizes 1000 vs. 1000
are used, the power reaches 0.99 or more. In general, whether the
SNPs are associated or independent does not affect the power
substantially, although in some cases the power is higher for
associated SNPs than independent SNPs.
The power displays a small FPR (tables 11, 12, and 13). Even if
small sample sizes 200 vs. 200 are used, there is still a small chance
that the model provides a false positive result for the three-locus
epistasis detection. The FPR was found to be consistent, regardless
of sample sizes and the degree of SNP-SNP associations.
Discussion
The phenotypic variation of a trait or disease is highly complex
given its polygenic inheritance and environmental influence. Most
original quantitative genetic models generally assume that allelic
effects are additive, with the size linearly proportional to the
Table 6. The x2 test statistics calculated to test the additive
and dominant effects at each SNP genotyped from DLG5.
SNP Additive Dominant
(a)( d)
Arg30Gln 1.196 14.316
(0.00015)
Glu514Gln 0 0.355
Pro979Leu 0 6.095
(0.0136)
Gly1066Gly 0.718 4.297
(0.0382)
Pro1371Gln 0 1.933
The p-values for those significant effects (in boldface) are given in parentheses.
doi:10.1371/journal.pone.0011384.t006
Table 7. The x2 test statistics calculated to test the two-SNP
epistasis between each pair of SNPs genotyped from DLG5.
SNP Pair a| |aa | |dd | |ad | |d
Arg30Gln|Glu514Gln 0.113 0.112 3.292 2.909
(0.040) (0.020)
Arg30Gln|Pro979Leu 0.118 1.085 3.958 2.405
(0.025) (0.040)
Arg30Gln|Gly1066Gly 0.005 1.393 1.453 1.741
Arg30Gln|Pro1371Gln 0.107 0.097 3.184 2.740
(0.050) (0.027)
Glu514Gln|Pro979Leu 0 1.211 0.314 0.340
Glu514Gln|Gly1066Gly 0.222 1.160 0.545 1.205
Glu514Gln|Pro1371Gln 0 0.500 0.107 0.567
Pro979Leu|Gly1066Gly 0.261 0.920 0.001 0.607
Pro979Leu|Pro1371Gln 0 0.401 1.434 0.045
Gly1066Gly|Pro1371Gln 0.290 1.584 1.543 1.907
The p-values for those significant effects (in boldface) are given in parentheses.
doi:10.1371/journal.pone.0011384.t007
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SNP Triplet a| |a| |aa | |a| |da | |d| |aa | |d| |dd | |a| |ad | |a| |dd | |d| |ad | |d| |d
Arg30Ln|Glu514Gln|Pro979Leu 0.465 1.274 0.008 0.202 7.437 2.780 3.291 1.533
(0.0025) (0.045) (0.025)
Arg30Ln|Glu514Gln|Gly1066Gly 0.010 3.038 0.054 1.499 2.469 0.340 0.815 0.134
Arg30Ln|Glu514Gln|Pro1371Gln 0.426 0.390 0.027 0.183 5.818 2.040 2.329 1.011
(0.008)
Arg30Ln|Pro979Leu|Gly1066Gly 0.002 2.460 0.576 0.772 3.140 0.250 1.151 0.057
Arg30Ln|Pro979Leu|Pro1371Gln 0.448 0.315 1.601 0.014 7.061 2.411 2.438 1.127
(0.0035)
Arg30Ln|Gly1066Gly|Pro1371Gln 0.005 1.880 4.250 2.618 3.076 1.652 0.814 0.644
(0.020) (0.050)
Glu514Gln|Pro979Leu|Gly1066Gly 1.101 2.096 0.046 0.908 1.447 1.158 0.120 0.774
Glu514Gln|Pro979Leu|Pro1371Gln 0 0.858 2.262 0.009 0.687 0.672 0.262 0.015
Glu514Gln|Gly1066Gly|Pro1371Gln 1.191 3.457 3.324 1.994 1.180 1.832 1.716 1.817
(0.040) (0.045)
Pro979Leu|Gly1066Gly|Pro1371Gln 1.322 3.298 2.727 1.756 0.100 0.436 1.082 1.255
(0.050)
The p-values for those significant effects (in boldface) are given in parentheses.
doi:10.1371/journal.pone.0011384.t008
Table 9. Genetic effect components of different three-locus genotypic values.
Genotype a1 a2 a3 d1 d2 d3 ia1a2 ia2a3 ia1a3 id1d2 id2d3 id1d3 ia1d2 ia1d3 ia2d3 id1a2 id2a3 id1a3 ia1a2a3 id1a2a3 ia1d2a3 ia1a2d3 ia1d2d3 id1a2d3 id1d2a3 id1d2d3
AABBCC +++ +++ +
AABBCc ++ ++ ++ +
AABBcc ++{ + {{ {
AABbCC +++ + + + +
AABbCc ++ + + + + +
AABbcc + { + { + {{
AAbbCC + { + {{+ {
AAbbCc + { + { + {{
AAbbcc + {{ {+ { +
AaBBCC + + + + + + +
AaBBCc +++ + + + +
AaBBcc + 2 + 2 + 2 2
AaBbCC +++ + + + +
AaBbCc ++ +++ +
AaBbcc { ++ + {{ {
AabbCC 2 + + 2 2 + 2
AabbCc { ++ + {{ {
Aabbcc 2 2 + + 2 2 +
aaBBCC { ++ { + {{
aaBBCc { ++ {{ + {
aaBBcc { + {{ { ++
aaBbCC { ++ {{ + {
aaBbCc { ++ + {{ {
aaBbcc {{++{{ +
aabbCC {{++ {{ +
aabbCc {{ ++ {{ +
aabbcc {{{ +++ {
The genotypic value containing the dominant | additive | additive epistasis are in boldface.
doi:10.1371/journal.pone.0011384.t009
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there are genetic interactions between different alleles at the same
locus (dominance). It is now recognized that the interactions
between different loci (epistasis) within gene networks may play an
important role [14,15]. More recent evidence shows that high-
order epistasis among more than two genes may form a crucial
component in genetic interaction networks [9,11,17,18]. In fact,
quantitative genetic analyses have detected high-order epistatic
effects in plants. For example, high-order epistasis could be
correlated with the aggressiveness of the isolate of Phytophthora
capsici through influencing double crosses among different loci at
meiosis [28]. Wu [29] used a mating design with clonal replicates
to identify the significant contribution of high-order epistasis to
genetic variation in stem wood growth traits in poplars.
An increasing availability of high-throughput SNP data has led
to the development of various statistical approaches for effectively
analyzing epistasis among multiple polymorphisms, including
logistic regression, multifactor dimensionality reduction (MDR),
Bayesian analysis, and machine learning [15,21,30–32]. In this
article, we developed a general model for detecting the episatsis of
any order in case-control genetic association studies by integrating
traditional quantitative genetic principles. Despite the existence,
high-order epistasis may be obscured by metabolic network
redundancy [17]. The integration of quantitative genetic princi-
ples makes our approach capable to identify high-order epistatic
interactions with genetic relevance. The model was tested by
simulation studies. It displays adequate power for the detection of
high-order epistasis with a modest sample size; for example, 400
cases vs. 400 controls. When sample sizes of cases and controls
increase to 1000 vs. 1000, which is currently not a problem for
most genetic association studies, the model has almost full power
to detect three-locus epistasis of different forms. Even if a small size
of samples (say 200 vs. 200), the new model has a low false positive
rate for epistatic detection. The practical application of the model
is validated by analyzing a real data set for the genetic study of
inflammatory bowel disease. The model detected significant three-
locus epistatic interactions among different SNPs genotyped from
a candidate gene DLG5 [27].
Our model allows the characterization of epistasis of any order.
Its implementation into a practical setting of genome-wide
association studies is challenged by an exponentially increasing
number of SNP-SNP combinations. To make this tractable, one
may incorporate optimization techniques into our model, allowing
the selection of the most important combinations. An additional
issue is to determine the critical threshold with multiple correlated
SNPs in genome-wide association studies. An empirical approach
for determining a genome-wide threshold is to employ non-
parametric permutation testing (see ref. [21,30,33–35]). Lastly, the
model is developed to detect multilocus epistasis at the SNP level,
but given recent discoveries for the importance of haplotypes in
trait control [36–39], the model should be extended to consider
high-order interactions expressed by different haplotypes. In the
current model specification, we choose controls that are matched
for cases in terms of biological, environmental, or demographical
factors. When such matches are not possible, we need to embed
these factors as covariates into the model, in which the interactions
between genes and these factors can be tested. Third, the model
Table 10. The genetic effect components of four particular
genotypes, AaBBCC, AaBBcc, AabbCC, and Aabbcc at three
SNPs, Arg30Ln, Glu514Gln, and Pro979Leu, which contain the
dominant|additive|additive three-locus epistasis.
Genotype a2 a3 d1 ia2a3 id1a2 id1a3 id1a2a3
AaBBCC Cases {16 16 {11 {16 11 {11 11
Controls {10 10 {2 {10 2 {22
Difference ({6) (6) ({9) ({6) (9) ({9) (9)
AaBBcc Cases {16 {16 {11 16 11 {11 {11
Controls {10 {10 {21 0 2 {2 {2
Difference ({6) ({6) ({9) (6) (9) ({9) ({9)
AabbCC Cases 16 16 {11 16 {11 {11 {11
Controls 10 10 {21 0 {2 {2 {2
Difference (6) (6) ({9) (6) ({9) ({9) ({9)
Aabbcc Cases 16 {16 {11 {16 {11 {11 11
Controls 10 {10 {2 {10 {2 {22
Difference (6) ({6) ({9) ({6) ({9) ({9) (9)
doi:10.1371/journal.pone.0011384.t010
Table 11. Power and false positive rates (FPR) for the
detection of three-locus epistasis among associated and
independent SNPs for 200 cases and 200 controls.
Associated Independent
Epistasis Power FPR Power FPR
Additive|additive|additive 61.2 4.9 51.8 4.0
Additive|additive|dominant 56.7 4.8 45.2 5.3
Additive|dominant|dominant 49.3 5.1 48.4 4.7
Dominant|dominant|dominant 51.0 6.0 56.1 6.8
doi:10.1371/journal.pone.0011384.t011
Table 12. Power and false positive rates (FPR) for the
detection of three-locus epistasis among associated and
independent SNPs for 400 cases and 400 controls.
Associated Independent
Epistasis Power FPR Power FPR
Additive|additive|additive 85.0 5.8 79.6 5.4
Additive|additive|dominant 84.2 4.5 78.6 6.0
Additive|dominant|dominant 77.6 5.6 76.8 7.5
Dominant|dominant|dominant 79.8 7.5 86.6 6.0
doi:10.1371/journal.pone.0011384.t012
Table 13. Power and false positive rates (FPR) for the
detection of three-locus epistasis among associated and
independent SNPs for 1000 cases and 1000 controls.
Associated Independent
Epistasis Power FPR Power FPR
Additive|additive|additive 99.8 5.9 99.1 5.6
Additive|additive|dominant 99.6 4.1 99.3 6.3
Additive|dominant|dominant 99.2 5.8 98.0 5.9
Dominant|dominant|dominant 98.6 8.7 99.7 6.6
doi:10.1371/journal.pone.0011384.t013
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effect of a gene. The results about high-order epistasis detection
using the this and extended models could be used for iterative
model building and functional annotation of genes. Future
applications of these results includes analysis of the metabolic
networks of pathogenic organisms and generation of epistatic
candidate models for genome-wide association studies.
Supporting Information
Text S1 Mathematical algorithm.
Found at: doi:10.1371/journal.pone.0011384.s001 (0.14 MB
PDF)
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